Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
Wei Wang, Najah Albadari, Yi Du, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 414-453
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

It’s all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma
Rebeca Yakubov, Ramneet Kaloti, Phooja Persaud, et al.
Journal of Neuro-Oncology (2025)
Open Access
Structure and function of MDM2 and MDM4 in health and disease
Ivy Zhu, Amy Lloyd, William R. Critchley, et al.
Biochemical Journal (2025) Vol. 482, Iss. 04, pp. 241-262
Open Access
Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells
Rati Lama, Joseph M. Fose, Diana Martı́n, et al.
Molecules (2025) Vol. 30, Iss. 1, pp. 186-186
Open Access
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis
Vishesh Khanna, Gohar Eslami, Rochelle Reyes, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics
Xiaoqiang Cui, Teng Huang, Tianyi Jiang, et al.
Cancer Letters (2025) Vol. 614, pp. 217540-217540
Closed Access
Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment
Francesca Sardina, Federica Polverino, Sonia Valentini, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Chromatin Immunoprecipitation Reveals p53 Binding to G-Quadruplex DNA Sequences in Myeloid Leukemia Cell Lines
Libuše Kratochvilová, Alessandra Dinová, Natália Valková, et al.
ACS Bio & Med Chem Au (2025)
Open Access
A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins
Ishaar P. Ganesan, Hiroaki Kiyokawa
Cancers (2025) Vol. 17, Iss. 4, pp. 626-626
Open Access
Dual inhibitor of MDM2 and NFAT1 for experimental therapy of breast cancer: in vitro and in vivo anticancer activities and newly discovered effects on cancer metabolic pathways
Wei Wang, Mariela C Aguilar, Sayantap Datta, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target
Fabio Sias, Stefano Zoroddu, Rossana Migheli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1973-1973
Open Access
Harnessing p53 for targeted cancer therapy: new advances and future directions
Zdeněk Andrysík, Joaquı́n M. Espinosa
Transcription (2025), pp. 1-44
Open Access
Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian
Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2329-2329
Open Access | Times Cited: 4
Insights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning
Wanchun Yang, Jian Wang, Lu Zhao, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3377-3377
Open Access | Times Cited: 3
E3 ubiquitin ligase TRIM31: A potential therapeutic target
Nian-Hua Deng, Zhen Tian, Ying-Jiao Zou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116846-116846
Open Access | Times Cited: 2
An MDM2 degrader shows potent cytotoxicity to MDM2-overexpressing acute lymphoblastic leukemia cells with minimal toxicity to normal cells/tissues
Tao Liu, Lubing Gu, Anna Mui, et al.
Cancer Letters (2024) Vol. 598, pp. 217126-217126
Open Access | Times Cited: 1
Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade
Pingping Han, Suhua Wei, Huaiyu Wang, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 1
An update patent review of MDM2-p53 interaction inhibitors (2019–2023)
Aleksandra Twarda‐Clapa
Expert Opinion on Therapeutic Patents (2024)
Closed Access | Times Cited: 1
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy
Seyed Esmaeil Ahmadi, Elahe Rahimian, Samira Rahimi, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation
Rati Lama, Wenjie Wu, Cory Mavis, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Phytochemical and Biological Investigations of Crude Extracts of Astragalus pisidicus
Esra Aydemir, Elif Odabaş Köse, Serap Özkaya Gül, et al.
Pharmaceuticals (2024) Vol. 18, Iss. 1, pp. 10-10
Open Access | Times Cited: 1
Targeting Hdm2 and Hdm4 in Anticancer Drug Discovery: Implications for Checkpoint Inhibitor Immunotherapy
Monde Ntwasa
Cells (2024) Vol. 13, Iss. 13, pp. 1124-1124
Open Access
Screening and Identification of Potentials Molecules Involved in the Radiation Induced Osteoblast Damage
Yunyun Cheng, Jiguo Lin, Gang Zhao, et al.
(2024)
Open Access
Response by Shridhar et al to Letter Regarding Article, “MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy”
Puneeth Shridhar, Soumojit Pal, Nicolas G. Clavere, et al.
Circulation (2024) Vol. 150, Iss. 9
Closed Access
Immunosuppressive role of benzo[a]pyrene exposure in prostate cancer progression
Zhijin Zhang, Wentao Zhang, Huan Wang, et al.
Journal of Environmental Sciences (2024)
Closed Access
MDM2 up-regulates the energy metabolism in NSCLC in a p53-independent manner
Elizaveta Fefilova, Yulia Kirdeeva, Sergey Parfenyev, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 743, pp. 151169-151169
Closed Access
Page 1 - Next Page

Scroll to top